Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation

Abstract Human leukocyte antigen (HLA) antibodies are usually “epitope” and not “antigen” specific. This work presents an interesting case concerning Luminex median fluorescence intensity (MFI) levels in antibodies considered low risk (

Saved in:
Bibliographic Details
Published in:Human immunology 2012-05, Vol.73 (5), p.522-525
Main Authors: Bosch, Alexandre, Llorente, Santiago, Diaz, Julio A, Salgado, Gema, López, Manuela, Boix, Francisco, López-Hernández, Ruth, González-Soriano, María J, Campillo, José A, Moya-Quiles, María R, Perez-Lopez, Noelia, Minguela, Alfredo, Jimeno, Luisa, Álvarez-López, María R, Muro, Manuel
Format: Article
Language:English
Subjects:
Adult
Allergy and Immunology
Antibodies, Monoclonal, Murine-Derived - administration & dosage
Biopsy
Cross Reactions
Cross-matching
Epitopes
Female
Fluorescence
Graft Rejection - prevention & control
Graft Survival - immunology
Histocompatibility Testing - methods
Histocompatibility Testing - standards
HLA antibodies
HLA Antigens - blood
HLA Antigens - immunology
Humans
Immunoglobulins, Intravenous - administration & dosage
Isoantibodies - blood
Isoantibodies - immunology
Kidney - immunology
Kidney - pathology
Kidney Function Tests
Kidney transplant
Kidney Transplantation - immunology
Kidney Transplantation - pathology
Median fluorescence intensity
Methylprednisolone - administration & dosage
Plasmapheresis
Risk Assessment
Rituximab
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Human leukocyte antigen (HLA) antibodies are usually “epitope” and not “antigen” specific. This work presents an interesting case concerning Luminex median fluorescence intensity (MFI) levels in antibodies considered low risk (
ISSN:0198-8859
1879-1166
DOI:10.1016/j.humimm.2012.02.020